España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Oncolytics Biotech
ONCY
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.00
0.03
3.19%
At close: -
$0.9600
-0.04
-4.09%
After Hours: 7:41 PM EDT
Get Report
Comment
Oncolytics Biotech (ONCY) Forecast
News
Earnings
Oncolytics Biotech (ONCY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Oncolytics Biotech (NASDAQ:ONCY) Stock
Oncolytics Biotech Stock (NASDAQ: ONCY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 18, 2024
Oncolytics Biotech Reveals Presentation Of Tw...
Benzinga Newsdesk
Tuesday, December 03, 2024
Oncolytics Biotech Completes Initial Safety P...
Benzinga Newsdesk
Thursday, November 14, 2024
RBC Capital Reiterates Outperform on Oncolyti...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Oncolyt...
Benzinga Newsdesk
Tuesday, November 12, 2024
Oncolytics Biotech Reported Q3 $19.6M In Cash...
Benzinga Newsdesk
Oncolytics Biotech Q3 2024 GAAP EPS C$(0.12) ...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, November 11, 2024
Earnings Preview: Oncolytics Biotech
Benzinga Insights
Friday, October 04, 2024
Oncolytics Biotech shares are trading higher ...
Benzinga Newsdesk
Oncolytics Biotech Announces Key Progress And...
Nabaparna Bhattacharya
Thursday, September 19, 2024
HC Wainwright & Co. Reiterates Buy on Oncolyt...
Benzinga Newsdesk
Oncolytics Reports Clinical Results From BRAC...
Benzinga Newsdesk
Wednesday, August 21, 2024
HC Wainwright & Co. Reiterates Buy on Oncolyt...
Benzinga Newsdesk
Monday, August 05, 2024
RBC Capital Reiterates Outperform on Oncolyti...
Benzinga Newsdesk
Thursday, August 01, 2024
Oncolytics Biotech Q2 GAAP EPS $(0.07), Inlin...
Benzinga Newsdesk
Thursday, June 27, 2024
Oncolytics Biotech Advances Breast Cancer Tri...
Benzinga Newsdesk
Monday, June 24, 2024
Oncolytics Biotech Chair Wayne Pisano To Serv...
Benzinga Newsdesk
Thursday, June 20, 2024
Oncolytics Biotech Begins New Study for Advan...
Benzinga Newsdesk
Friday, May 24, 2024
Oncolytics Biotech Discloses American Society...
Benzinga Newsdesk
Wednesday, May 15, 2024
Oncolytics Biotech Enters Preliminary Collabo...
Benzinga Newsdesk
Tuesday, May 14, 2024
HC Wainwright & Co. Reiterates Buy on Oncolyt...
Benzinga Newsdesk
Thursday, May 09, 2024
Oncolytics Biotech Q1 EPS $(0.07) Beats $(0.0...
Benzinga Newsdesk
Oncolytics Biotech Receives Regulatory Cleara...
Benzinga Newsdesk
Thursday, April 25, 2024
Oncolytics Reports Acceptance Of Two Abstract...
Benzinga Newsdesk
Thursday, April 11, 2024
Oncolytics Biotech Has Submitted Type C Meeti...
Benzinga Newsdesk
Oncolytics Biotech Reports Submission Of A Ty...
Benzinga Newsdesk
Thursday, April 04, 2024
Raymond James Initiates Coverage On Oncolytic...
Benzinga Newsdesk
Friday, March 08, 2024
HC Wainwright & Co. Maintains Buy on Oncolyti...
Benzinga Newsdesk
Thursday, March 07, 2024
Recap: Oncolytics Biotech Q4 Earnings
Benzinga Insights
Oncolytics Biotech Q4 EPS $(0.04) Beats $(0.1...
Benzinga Newsdesk
Earnings Scheduled For March 7, 2024
Benzinga Insights
Wednesday, March 06, 2024
A Preview Of Oncolytics Biotech's Earnings
Benzinga Insights
Tuesday, March 05, 2024
Oncolytics Biotech Submits Amendment To GOBLE...
Benzinga Newsdesk
Wednesday, February 14, 2024
HC Wainwright & Co. Reiterates Buy on Oncolyt...
Benzinga Newsdesk
Friday, January 19, 2024
HC Wainwright & Co. Reiterates Buy on Oncolyt...
Benzinga Newsdesk
Thursday, January 04, 2024
HC Wainwright & Co. Reiterates Buy on Oncolyt...
Benzinga Newsdesk
Oncolytics Biotech Says It Expects To Initiat...
Benzinga Newsdesk
Thursday, December 07, 2023
Oncolytics Biotech Presented Additional Trans...
Benzinga Newsdesk
Monday, November 13, 2023
HC Wainwright & Co. Maintains Buy on Oncolyti...
Benzinga Newsdesk
Thursday, November 09, 2023
Oncolytics Provides Update on Pancreatic Canc...
Benzinga Newsdesk
Friday, November 03, 2023
Earnings Scheduled For November 3, 2023
Benzinga Insights
Oncolytics Biotech Q3 EPS Loss Widens To $(0....
Benzinga Newsdesk
Thursday, November 02, 2023
Oncolytics Biotech's Earnings Outlook
Benzinga Insights
Monday, October 23, 2023
Oncolytics Biotech Achieves Success Criteria ...
Benzinga Newsdesk
Tuesday, September 26, 2023
The Pancreatic Cancer Action Network Selects ...
Benzinga Newsdesk
Oncolytics Biotech Bags $5M Therapeutic Accel...
Benzinga Newsdesk
Wednesday, August 16, 2023
HC Wainwright & Co. Reiterates Buy on Oncolyt...
Benzinga Newsdesk
Tuesday, August 15, 2023
RBC Capital Reiterates Outperform on Oncolyti...
Benzinga Newsdesk
Monday, August 14, 2023
CORRECTION: Oncolytics Biotech Q2 EPS $(0.09)...
Benzinga Newsdesk
Oncolytics Biotech Q2 EPS $(0.09), Inline; Ca...
Benzinga Newsdesk
Show More
